A randomized, double-blind, placebo-controlled, Phase 1/2a trial protocol to assess the safety and efficacy of TAK-101 administered by microneedles in patients with celiac disease

Autor: Juan Felipe Garzon
Rok vydání: 2022
Předmět:
Zdroj: Principles and Practice of Clinical Research Journal. 8:37-48
ISSN: 2378-1890
Databáze: OpenAIRE